» Articles » PMID: 19579874

Thymoma Associated with Myasthenia and Autonomic Anti-Hu Paraneoplastic Neuropathy

Overview
Journal Tumori
Publisher Sage Publications
Specialty Oncology
Date 2009 Jul 8
PMID 19579874
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Along with myasthenia, other paraneoplastic neurological syndromes (PNS) may occur in thymoma. Anti-Hu antibodies and a clinical "anti-Hu syndrome" characterized by encephalitis and/or painful neuropathies have been reported in only three patients at the time of the diagnosis of thymoma. We describe a severe anti-Hu-related autonomic neuropathy with gastrointestinal paresis and intestinal pseudo-obstruction with malabsorption that occurred concomitantly with the worsening of myasthenic symptoms long after the initial diagnosis of thymoma in a young patient. The clinical anti-Hu syndrome preceded the radiological diagnosis of thymoma recurrence. Treatment with plasma exchange led to a transient improvement of neurological symptoms.

Citing Articles

Subacute Sensory Ataxic Neuronopathy With Thymoma Presenting Marked Improvement After Steroid Therapy.

Nishijima H, Onodera K, Sato N, Ueno T, Hikichi H, Haga R Front Neurol. 2019; 10:268.

PMID: 30949123 PMC: 6435522. DOI: 10.3389/fneur.2019.00268.


Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study.

Li J, Lin W Medicine (Baltimore). 2018; 97(18):e0649.

PMID: 29718880 PMC: 6392975. DOI: 10.1097/MD.0000000000010649.


MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review.

Ricigliano V, Fossati B, Saraceno L, Cavalli M, Bazzigaluppi E, Meola G Front Neurosci. 2018; 12:17.

PMID: 29416500 PMC: 5787932. DOI: 10.3389/fnins.2018.00017.


Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.

Banna G, Sheel A, Sheel V, Bille A, Routledge T, Fernando S Future Oncol. 2017; 13(27):2429-2439.

PMID: 29121777 PMC: 5967362. DOI: 10.2217/fon-2017-0236.


Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma.

Aliprandi A, Terruzzi A, Rigamonti A, Bazzigaluppi E, Tremolizzo L, Ferrarese C Neurol Sci. 2015; 36(8):1501-3.

PMID: 25686614 DOI: 10.1007/s10072-015-2113-5.